Dr. Reddy's Laboratories Ltd.

BSE

Price on BSE 11 Aug,15:28 LIVE

1,205.00

+47.65

(+4.12%)

Volume :
127,259.00

Prev Close :
1,157.35

Day's H/L (Rs.) :
1,206.75 - 1,155.20

52wk H/L (Rs.) :
1,414.40 - 1,080.05

Mkt Cap (Rs. Cr) :
100,581.36

NSE

Price on NSE 11 Aug,15:58 LIVE

1,205.00

+46.20

(+3.99%)

Volume :
3,936,813.00

Prev Close :
1,158.80

Day's H/L (Rs.) :
1,206.60 - 1,155.10

52wk H/L (Rs.) :
1,414.90 - 1,101.00

Mkt Cap (Rs. Cr) :
0.00

Market News

Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com 22 hour(s) ago

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com 23 Jul 2026

Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com 19 Jul 2026

Indian Pharma Bets Beyond US Generics
Rediff.com 26 Jun 2026

Report Card - Dr. Reddy's Laboratories Ltd.

PE Ratios

30.01

EPS (Rs.)

38.56

Sales (Rs. Cr)

5,136.60

Face Value (Rs.)

Net Profit Margin(%)

15.68

Last Bonus

1:1

Last Dividend(%)

800

Return on Average Equity

10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US

Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.

Aug 04, 2026 13:33

Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low

Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.

Jul 23, 2026 11:00

Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices

Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.

Jul 22, 2026 19:03

Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue

Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.

Jul 22, 2026 17:19

US Tariffs on Generic Drugs: India''s Pharma Exports at Risk

GTRI warns US tariffs on generic medicines could significantly impact India''s largest pharma export market. Trump''s plan aims to reshore production, affecting Indian companies.

Jul 22, 2026 14:24

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

TCS & Google Cloud Launch Gemini Experience Center in Mexico

TCS and Google Cloud open a Gemini Experience Center in Mexico City, offering 3,000+ AI agents for industry-specific solutions across various sectors.

Aug 11, 2026 16:26

Stock Markets Decline: Crude Oil Prices Hit Sentiment, Sensex Drops

Indian stock markets, Sensex & Nifty, fell as elevated crude oil prices and geopolitical uncertainties dented investor sentiment. Sensex dropped 388 points.

Aug 11, 2026 16:05

Rupee Falls to 95.43 Against US Dollar Amid Oil Price Surge

The Indian rupee fell 13 paise to 95.43 against the US dollar, driven by rising global crude oil prices and geopolitical uncertainties. Foreign inflows offered some support.

Aug 11, 2026 15:59

DBS Bank Funds K Raheja Corp''s Pune Commercial Tower

DBS Bank India extends Rs 520-cr credit to K Raheja Corp for developing a 1.1 million sqft commercial tower in Pune. Also, Certus Capital commits Rs 1000 Cr & CHRIST University partners IBM for AI.

Aug 11, 2026 15:57

HCLTech Probe Finds No Systems Breach After Data Exposure Claims

HCLTech''s initial probe into hacker claims of employee data exposure found no system breach or client engagement. Data may be limited & dated. Investigation ongoing.

Aug 11, 2026 15:54

More News »

Top News